Li M, Hou X, Chen J, Zhang B, et al. ALK fusion variant 3a/b, concomitant mutations, and high PD-L1 expression were
associated with unfavorable clinical response to second-generation ALK TKIs in
patients with advanced ALK-rearranged non-small cell lung cancer (GASTO 1061). Lung Cancer 2022;165:54-62.
PMID: 35091210